Vivus' EvaMist Gets FDA Approval
Monday July 30, 8:41 am ET
Licensee KV Pharmaceutical's Says Vivus' Menopause Drug EvaMist Approved in the U.S.
NEW YORK (AP) -- KV Pharmaceutical Co. and Vivus Inc. said Monday the Food and Drug Administration approved Vivus' EvaMist for symptoms associated with menopause.
St. Louis-based KV Pharmaceutical licensed U.S. marketing rights to the drug from Mountain View, Calif.-based Vivus in March. Vivus is eligible to receive a $140 million cash payment upon approval of the drug. The deal also calls for two separate milestone payments of up to $30 million. Those payments are based on annual sales levels.
EvaMist is expected to be launched during the second half of KV Pharmaceutical's fiscal year 2008.
evamist gets fda approval hottttttt
Featured News
Add ACR (ASX) to my watchlist
|
|||||
Last
6.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.31M |
Open | High | Low | Value | Volume |
6.3¢ | 6.4¢ | 6.3¢ | $10.36K | 164.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 83332 | 6.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.4¢ | 4393 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 83332 | 0.060 |
1 | 20000 | 0.059 |
1 | 17241 | 0.058 |
1 | 10000 | 0.055 |
1 | 92500 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.063 | 9400 | 1 |
0.064 | 4393 | 1 |
0.066 | 38550 | 1 |
0.067 | 46144 | 4 |
0.068 | 50000 | 1 |
Last trade - 13.50pm 15/08/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online